Evidence map›Paper›PMID 42457729›Full record

ArticleNature communications2026

A unified catalytic mechanism in bifunctional DNA glycosylases with an evolutionarily conserved aspartate-lysine dyad.

Aleem Syed, Leonardo F Serafim, Andrew S Arvai, Irina G Minko, Henry Y H Tang, Joy L Huffman, Clifford D Mol, Kenichi Hitomi, Altaf H Sarker, Sudip Parikh and 9 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Aleem Syed *Department of Molecular and Cellular Oncology, Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. aleem_syed@dfci.harvard.edu.ORCID http://orcid.org/0000-0001-7942-3900
Leonardo F Serafim *Department of Chemistry, Georgia State University, Atlanta, GA, USA.
Andrew S ArvaiThe Skaggs Institute for Chemical Biology and Department of Molecular Biology, The Scripps Research Institute, La Jolla, CA, USA.
Irina G MinkoOregon Institute of Occupational Health Sciences, Oregon Health & Science University, Portland, OR, USA.
Henry Y H TangDepartment of Molecular and Cellular Oncology, Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0001-7600-6263
Joy L HuffmanThe Skaggs Institute for Chemical Biology and Department of Molecular Biology, The Scripps Research Institute, La Jolla, CA, USA.
Clifford D MolThe Skaggs Institute for Chemical Biology and Department of Molecular Biology, The Scripps Research Institute, La Jolla, CA, USA.
Kenichi HitomiThe Skaggs Institute for Chemical Biology and Department of Molecular Biology, The Scripps Research Institute, La Jolla, CA, USA.
Altaf H SarkerBiological Systems and Engineering, Lawrence Berkeley National Lab, Berkeley, CA, USA.ORCID http://orcid.org/0000-0001-6868-8460
Sudip ParikhThe Skaggs Institute for Chemical Biology and Department of Molecular Biology, The Scripps Research Institute, La Jolla, CA, USA.
Chi-Lin TsaiDepartment of Molecular and Cellular Oncology, Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0002-0365-2405
Albino BacollaDepartment of Molecular and Cellular Oncology, Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0003-0206-8423
David S ShinThe Skaggs Institute for Chemical Biology and Department of Molecular Biology, The Scripps Research Institute, La Jolla, CA, USA.
Richard P CunninghamDepartment of Biological Sciences, University at Albany-State University of New York, Albany, NY, USA.
Shigenori IwaiGraduate School of Engineering Science, Osaka University, Osaka, Japan.
Dipanjan ChowdhuryDivision of Radiation and Genome Instability, Department of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0001-5645-3752
R Stephen LloydOregon Institute of Occupational Health Sciences, Oregon Health & Science University, Portland, OR, USA.ORCID http://orcid.org/0000-0001-7273-372X
Ivaylo IvanovDepartment of Chemistry, Georgia State University, Atlanta, GA, USA. iivanov@gsu.edu.ORCID http://orcid.org/0000-0002-5306-1005
John A TainerDepartment of Molecular and Cellular Oncology, Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. jtainer@mdanderson.org.ORCID http://orcid.org/0000-0003-1659-2429

Funding

Transcription-Coupled & Replication-Associated Excision RepairP01CA092584 · NCI · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI TANYA T PAULL · 2001 to 2026
$89.6M
Mesoscale and Nanoscale Technologies Integrated by Structures for DNA Repair Complexes (MANTIS-DRC)R35CA220430 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI John A. Tainer · 2018 to 2026
$7.6M
NCI NIH HHS P01 CA092584NCI NIH HHS R35 CA220430U.S. Department of Health & Human Services | NIH | Office of Extramural Research, National Institutes of Health (OER) P01CA092584U.S. Department of Health & Human Services | NIH | Office of Extramural Research, National Institutes of Health (OER) R35CA220430
6 · The paper itself

Abstract

Bifunctional glycosylases, OGG1 for purines and NTH1 for pyrimidines, repair oxidized DNA bases via consecutive glycosylase and AP-lyase reactions, yet their catalytic relationships and lyase activity's biological relevance remain unresolved. Here, we solved crystal structures of archaeal and human Ogg1 and Nth1 captured in key damage-recognition and catalysis-ready states, complemented by ab initio molecular dynamics simulations of their complete reaction trajectories. We thereby define a unified catalytic mechanism for OGG1 and NTH1 conserved over three billion years, distinct from the canonical oxocarbenium-ion mechanism of monofunctional glycosylases. While divergent in their oxidized substrate recognition, their chemistry converged on ribose protonation and ring opening that precede the deglycosylation step. Acid-base catalysis mediated by a conserved aspartate-lysine dyad lowers the C-N bond cleavage barrier, while the excised 8-oxoG base in OGG1 or a conserved aspartate in NTH1 facilitates the AP-lyase reaction. Moreover, structures of human OGG1 bound to product DNA and to product DNA plus a potent small-molecule agonist F51, within the catalytic pocket, reveal that agonists accelerate enzyme turnover by promoting product release. Together, these findings clarify the catalytic logic of bifunctional glycosylases, enabling the development of chemical tools to interrogate lyase activity and therapeutics for oxidative damage in cancer and aging.

Indexed as

Aspartic AcidDeoxyribonuclease (Pyrimidine Dimer)DNA GlycosylasesLysineBiocatalysisCatalysisCatalytic DomainCrystallography, X-RayDNAEvolution, MolecularHumansMolecular Dynamics SimulationAspartic AcidDeoxyribonuclease (Pyrimidine Dimer)DNADNA GlycosylasesLysineNTHL1 protein, humanoxoguanine glycosylase 1, human

Identifiers

PMID42457729
PMCPMC13490550

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.